Crescent Grove Advisors, LLC

SEC CIK: 0001713520
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

SEEL holding history

Seelos Therapeutics, Inc. in every 13F filed by Crescent Grove Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SEEL overview All 13F holders of SEEL Full Q2 2026 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q3 2023

Holdings of SEEL by Crescent Grove Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−667−100.0%	Sold outConverted for a 1-for-30 split	Holders
Q3 2023	20,000	$3.68K	<0.1%	+20,000	New	Holders